High-Resolution CT vs. Angiography for Coronary Artery Disease
Trial Summary
What is the purpose of this trial?
Cardiac catheterization with invasive coronary angiography is the gold standard for determining the presence or absence of significant coronary heart disease (CHD). However, cardiac catheterization is costly and, as an invasive procedure, it is associated with some risk of adverse events, rarely even stroke, myocardial infarction, or death. Recent advances in multi-detector computed tomography angiography (CTA) have allowed rapid, noninvasive coronary artery imaging in patients with suspected CHD. CTA generally yields high accuracy for identifying patients with CHD when compared to cardiac catheterization. However, diagnostic accuracy is reduced in the setting of severe coronary artery calcification and coronary stents due to its inferior spatial resolution compared to cardiac catheterization. Because high-risk patients often have severe coronary calcification or stents, the application of CTA has been particularly limited in this important patient group. Recently, an ultrahigh-resolution CT scanner was released which has shown promise to overcome the limitation of conventional CTA in the setting of severe coronary artery calcification or stents. This ultrahigh-resolution "precision" CT scanner (UHR-CT) contains detector rows with half the width than currently available systems (0.25 mm vs. 0.5 mm) resulting in approximately twice the spatial resolution. The purpose of this investigation is to test the hypothesis that high-resolution CTA is not inferior to the current standard of cardiac catheterization for identifying significant CHD in patients with high-risk characteristics, including severe coronary artery calcification and coronary stents. The investigators propose to enroll 50 patients over 24-30 months in this investigation as part of a multicenter study. Patients referred for cardiac catheterization with known CHD and suspected obstructive coronary artery stenosis will be included. All patients will undergo both cardiac catheterization and UHR-CT for determining significant CHD as defined by coronary functional assessment. The primary end point will be the diagnostic accuracy by area-under-curve (AUC) method for identifying patients with hemodynamically significant CHD.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment High-Resolution CT vs. Angiography for Coronary Artery Disease?
Coronary CT angiography is effective in diagnosing coronary artery disease, especially with newer technology like 64-slice and 320-slice CT scanners, which provide high-quality images and reliable results. It is particularly useful for patients at intermediate risk of coronary artery disease, offering detailed information about the type and amount of plaque in the arteries.12345
Is coronary CT angiography generally safe for humans?
How does CT Angiography differ from other treatments for coronary artery disease?
CT Angiography (CTA) is a non-invasive test that uses advanced imaging technology to create detailed pictures of the coronary arteries, allowing doctors to see blockages or plaque without needing to insert a catheter into the heart. Unlike invasive coronary angiography, CTA can provide more information about the type and amount of plaque in the arteries and is particularly useful for patients at intermediate risk of coronary artery disease.311121314
Research Team
Armin A Zadeh, MD
Principal Investigator
Johns Hopkins University
Eligibility Criteria
This trial is for adults aged 45-85 with a history of coronary heart disease (CHD), specifically those who have had a stenosis or revascularization, and are suspected to have obstructive coronary artery stenosis. It's not suitable for individuals with certain heart conditions, allergies to iodine contrast media, kidney issues, or uncontrolled heart rhythm problems.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Imaging
Participants undergo UHR-CT angiography and conventional coronary angiography
Follow-up
Participants are monitored for adverse events and diagnostic accuracy is assessed
Treatment Details
Interventions
- CT Angiography
- Invasive Coronary Angiography
CT Angiography is already approved in European Union, United States, Canada, Japan for the following indications:
- Diagnosis of coronary artery disease
- Detection of coronary stenosis
- Diagnosis of coronary artery disease
- Detection of coronary stenosis
- Evaluation of cardiac structure and function
- Diagnosis of coronary artery disease
- Detection of coronary stenosis
- Diagnosis of coronary artery disease
- Detection of coronary stenosis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Canon Medical Systems, USA
Industry Sponsor